“Illegal drug manufacturing, gender discrimination”… Pharmaceutical industry’heads up’ on subsequent negative issues

Recently, the pharmaceutical industry is suffering from negative issues such as illegal drug manufacturing, seizure and sex discrimination.

These issues are evaluated as serious in that they can shake the foundation of the organizational culture of pharmaceutical companies that require a higher ethical consciousness than any industry group.

Some have raised concerns that a series of incidents overcame the pandemic aftermath of the novel coronavirus infection (Corona 19) and recorded favorable results, putting cold water on the overall pharmaceutical industry, where public interest has risen.

According to the pharmaceutical industry on the 14th, cases of companies that manufacture drugs illegally, different from those recently approved or reported, occurred in a row.

On the 12th, the Ministry of Food and Drug Safety (Ministry of Food and Drug Safety) confirmed that non-preservation pharmaceuticals manufactured 4 drugs for sale manufactured by the company and 5 drugs consigned by other companies to manufacture differently from the license requirements. The Ministry of Food and Drug Safety decided to temporarily suspend manufacture and sale of the item and to collect it.

In addition, on the 10th of this month, the Ministry of Food and Drug Safety’s Central Investigation Group (SID) confiscated and searched Binex’s Busan factory, which illegally manufactured medicines that were different from what was also approved.

Previously, the Ministry of Food and Drug Safety stopped selling and recalled 6 items such as diabetes treatment and depression treatment products produced by Binex, as well as 24 companies and 32 products entrusted with consignment production.

An official from the Ministry of Food and Drug Safety said, “Through the Ministry of Health and Welfare and the Health Insurance Review and Assessment Service, we requested restrictions on prescriptions for the product in hospitals and clinics,” and said, “We plan to quickly complete the on-site investigation and necessary measures for Binex.”

Ildong Pharmaceutical is facing measles due to the search and seizure of the prosecution. Seoul Southern District Prosecutor’s Office Financial Research Division 1 recently seized and searched Ildong Holdings and Ildong Pharmaceutical headquarters in Seocho-gu, Seoul to obtain data on the division of Ildong Pharmaceutical and changes in stock holdings.

In the process of dividing Ildong Pharmaceutical’s personal and physical properties for the transition to a holding company between 2016 and 2017, the prosecution investigated whether there was intentional market price manipulation such as stimulating stock prices in the process of increasing the stake in order to secure management rights of the owner’s family including CEO Yoon Woong-seop. In the middle.

Jeil Pharm’s weak organizational ethics has risen on the cutting board. The Ministry of Employment and Labor said that a total of 15 violations of the labor relations law and workplace harassment were found in Jeil Pharmaceutical. Jeil Pharm’s executives assaulted a female employee were reported in some media.

According to an anonymous survey on the victimization experience for Jeil Pharm’s employees, 11.6% said that they or a colleague had or had experienced sexual harassment in the workplace.

In particular, more than half (53.9%) answered that they have experienced workplace bullying more than once in the last 6 months. The survey was conducted on 866 out of 945 employees.

In the case of Dong-A Pharmaceutical, the problem of sex discrimination triggered by a YouTube video comment that was released on the 5th of this month is spreading.

In this video containing Dong-A Pharm’s sanitary napkin product discount negotiation content, one netizen said, “Because I’m a woman, I didn’t go to the military, so what do you think about getting a lower salary than a man, do you agree?” In the process of hiring a new employee, he posted a comment stating that he had been asked gender discrimination, which soon led to the issue of gender discrimination.

Since then, Dong-A Pharm has dismissed the controversial HR team leader for three months and has been suspended for three months, but the controversy is not easily evolving, such as a boycott.

A professor of economics at a university said, “The pharmaceutical industry is a group that is involved in human life, so it requires a higher ethical consciousness than any other company.” “It’s unreasonable to dismiss it as a deviation from the company alone. Even for the growth of the pharmaceutical industry as a whole, it is time to prepare self-response and time for self-restraint to establish a correct corporate culture,” he advised.